<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3196">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04322123</url>
  </required_header>
  <id_info>
    <org_study_id>Brazil COVID Coalition I Trial</org_study_id>
    <nct_id>NCT04322123</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)</brief_title>
  <acronym>Coalition-I</acronym>
  <official_title>An Open-label, Randomized Controlled Trial of Hydroxychloroquine and Azithromycin for COVID-19 Infection on Hospitalized, Noncritical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital do Coracao</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Israelita Albert Einstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sirio-Libanes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brazilian Research In Intensive Care Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>EMS</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital do Coracao</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coronavirus (COVID-19) is a somewhat new and recognized infectious disease that is now
      spreading to several countries in the world, including Brazil. Hydroxychloroquine and
      azithromycin may be useful for treating those patients.

      COALITION I study aims to compared standard of care, hydroxychloroquine plus azithromycin and
      hydroxychloroquine monotherapy for treatment of hospitalized patients with COVID-19.

      COALITION I will recruit 630 patients with infection by COVID-19 (210 per arm). Ordinal
      endpoint of status at 15 days will be the primary endpoint.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current pandemic associated with coronavirus disease 2019 (COVID-19) represents a major
      global health challenge. There are no effective therapies for the management of COVID-19 that
      have been proven to improve clinical outcomes in this high-risk group of patients.
      Hydroxychloroquine and its combination with azithromycin have been suggested to improve viral
      clearance, but its effect on clinical outcomes remains uncertain.

      This is an open-label pragmatic multicentre randomized (concealed) clinical trial of 7 days
      of hydroxychloroquine (400 mg BID) plus azithromycin (500 mg once daily), hydroxychloroquine
      400 mg BID, or standard of care for moderately severe hospitalized patients with suspected or
      confirmed COVID-19 (in-patients with up to 4L/minute oxygen supply through nasal catheter).
      Patients are randomized in around 50 recruiting sites (630 patients with confirmed COVID-19;
      1:1:1; 210 patients per arm).

      The primary endpoint is a 7-level ordinal scale measured at 15-days: 1) not hospitalized,
      without limitations on activities; 2) not hospitalized, with limitations on activities; 3)
      hospitalized, not using supplementary oxygen; 4) hospitalized, using supplementary oxygen; 5)
      hospitalized, using high-flow nasal cannula or non-invasive ventilation; 6) hospitalized, on
      mechanical ventilation; 7) death. Secondary endpoints are the ordinal scale at 7 days, need
      for mechanical ventilation and rescue therapies during 15 days, need of high-flow nasal
      cannula or non-invasive ventilation during 15 days, length of hospital stay, in-hospital
      mortality, thromboembolic events, occurrence of acute kidney injury, defined as an increase
      in creatinine above 1.5 times the baseline value and number of days free of respiratory
      support at 15 days. Secondary safety outcomes include prolongation of QT interval on
      electrocardiogram, ventricular arrhythmias, and liver toxicity. The main analysis will
      consider all patients with confirmed COVID-19 in the groups they were randomly assigned.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of the clinical status</measure>
    <time_frame>15 days after randomization</time_frame>
    <description>Evaluation of the clinical status of patients on the 15th day after randomization defined by the Ordinal Scale of 7 points.
Alive at home without limitations on activities
Alive at home without limitations on activities
In the hospital without oxygen
In the hospital using oxygen
In the hospital using high-flow nasal catheter or non-invasive ventilation
In hospital, on mechanical ventilation
Dead</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ordinal scale in 7 days</measure>
    <time_frame>7 days after randomization</time_frame>
    <description>Evaluation of the clinical status of patients on the 7th day after randomization defined by the Ordinal Scale of 7 points.
Alive at home without limitations on activities
Alive at home without limitations on activities
In the hospital without oxygen
In the hospital using oxygen
In the hospital using high-flow nasal catheter or non-invasive ventilation
In hospital, on mechanical ventilation
Dead</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of intubation and mechanical ventilation</measure>
    <time_frame>7 days after randomization</time_frame>
    <description>Need of intubation and mechanical ventilation up to the 7th day after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of mechanical ventilation during hospital stay</measure>
    <time_frame>15 days after randomization</time_frame>
    <description>Use of mechanical ventilation during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of non-invasive ventilation</measure>
    <time_frame>7 days after randomization</time_frame>
    <description>Use of non-invasive ventilation up to the 7th day after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Length of Stay</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>Hospital Length of Stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>28 days after randomization</time_frame>
    <description>All-cause mortality rates during hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thromboembolic complications</measure>
    <time_frame>15 days after randomization</time_frame>
    <description>Occurrence of thromboembolic complications such as:
Deep vein thrombosis Pulmonary Embolism Stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute renal disfunction</measure>
    <time_frame>15 days after randomization</time_frame>
    <description>Occurrence of renal dysfunction, defined as an increase in creatinine above 1.5 times the baseline value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of days alive and free of respiratory support up to 15 days</measure>
    <time_frame>15 days</time_frame>
    <description>Number of days alive and free of respiratory support up to 15 days (DAFOR15), defined as the sum of days patients did not require supplementary oxygen, non-invasive ventilation, high-flow nasal catheter neither mechanical ventilation at 15 -days. Patients that perished during the 15-day window will receive zero DAFOR15.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Safety outcome on corrected QT interval</measure>
    <time_frame>At day 3 and 7 after enrollment</time_frame>
    <description>Corrected QT interval</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">630</enrollment>
  <condition>Coronavirus Infections</condition>
  <arm_group>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine after randomization, Hydroxychloroquine [400mg 2x/day, 12/12h] for 07 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydroxychloroquine + azithromycin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hydroxychloroquine + azithromycin. After randomization, Hydroxychloroquine [400mg 2x/day, 12/12h] + azithromycin [500mg 1x/day]) for 07 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard treatment protocol for 2019-nCoV infection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine Oral Product</intervention_name>
    <description>Hydroxychloroquine 400 mg BID</description>
    <arm_group_label>Hydroxychloroquine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hydroxychloroquine + azithromycin</intervention_name>
    <description>Hydroxychloroquine 400 mg BID + azithromycin 500 mg once a day</description>
    <arm_group_label>Hydroxychloroquine + azithromycin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected or confirmed COVID-19 admitted to inpatient units and
             intensive care units

        Exclusion Criteria:

          -  Need for oxygen supplementation &gt; 4 litters per min

          -  Patients using a high-flow nasal catheter

          -  Patients using non-invasive mechanical ventilation

          -  Patients using invasive mechanical ventilation

          -  Males and females aged &lt; 18 years

          -  Pregnancy

          -  Allergy to chloroquine or derivatives

          -  Allergy to azithromycin

          -  Patients that have already received more than one dose of either azithromycin or
             hydroxychloroquine before enrollment

          -  Patients with respiratory symptoms for more than 14 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Biasi, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital do Coração</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Otavio Berwanger</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Israelita Albert Einstein</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Geral Clériston Andrade</name>
      <address>
        <city>Feira De Santana</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ana Nery - HAN/SESAB</name>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HHospital SAMUR</name>
      <address>
        <city>Vitória Da Conquista</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Vitória da Conquista</name>
      <address>
        <city>Vitória Da Conquista</city>
        <state>BA</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Brasília</name>
      <address>
        <city>Brasilia</city>
        <state>DF</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto de Cardiologia do Distrito Federal</name>
      <address>
        <city>Brasília</city>
        <state>DF</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Maternidade São José - UNESC - Fundação Social Rural de Colatina</name>
      <address>
        <city>Colatina</city>
        <state>ES</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Vila da Serra</name>
      <address>
        <city>Nova Lima</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Santa Casa de Misericórdia de São João Del Rei</name>
      <address>
        <city>São João Del Rei</city>
        <state>MG</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Associação Evangélica Beneficente de Londrina - Hospital Evangélico de Londrina</name>
      <address>
        <city>Londrina</city>
        <state>PR</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Estadual do Cérebro Paulo Niemeyer</name>
      <address>
        <city>Rio De Janeiro</city>
        <state>RJ</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Geral de Caxias do Sul</name>
      <address>
        <city>Caxias do Sul</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Rita - Irmandade Santa Casa de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital São Francisco - Irmandade Santa Casa de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital São José</name>
      <address>
        <city>Criciuma</city>
        <state>SC</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Baía Sul - Baía Sul Medical Center</name>
      <address>
        <city>Florianópolis</city>
        <state>SC</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Nereu Ramos</name>
      <address>
        <city>Florianópolis</city>
        <state>Sc</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Unimed</name>
      <address>
        <city>Joinville</city>
        <state>SC</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Amor - Unidade Barretos (Fundação PIO XII)</name>
      <address>
        <city>Barretos</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Casa de Saúde Santa Marcelina</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Albert Einstein</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Beneficência Portuguesa - Real e Benemérita Associação Portuguesa de Beneficência</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital BP Mirante - Real e Benemérita</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital das Clínicas da FMUSP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital do Servidor Público Estadual - HSPE - IAMSPE</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital São Paulo - UNIFESP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sírio-Libanês</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital SEPACO</name>
      <address>
        <city>São Paulo</city>
        <state>S</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 24, 2020</study_first_submitted>
  <study_first_submitted_qc>March 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 26, 2020</study_first_posted>
  <last_update_submitted>May 28, 2020</last_update_submitted>
  <last_update_submitted_qc>May 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Azithromycin</mesh_term>
    <mesh_term>Hydroxychloroquine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Study Protocol</doc_type>
      <doc_url>https://www.medrxiv.org/content/10.1101/2020.05.19.20106997v1</doc_url>
      <doc_comment>Preprint of the Protocol</doc_comment>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

